DrugDashboards

Sumatriptan Succinate

sumatriptan succinate · SUMATRIPTAN SUCCINATE 4 mg/.5mL · Injection · Subcutaneous · Alembic Pharmaceuticals Inc.

NDC 62332-0656-01 · 2 SYRINGE in 1 CARTON / .5 mL in 1 SYRINGE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for sumatriptan succinate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $24.59 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA213518
TE code
AB
Approval date
Nov 6, 2025
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of sumatriptan succinate (Injection)

LabelerStrengthFirst seenLast seen
Alembic Pharmaceuticals Inc.SUMATRIPTAN SUCCINATE 4 mg/.5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals Inc.SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedSUMATRIPTAN SUCCINATE 4 mg/.5mLJul 15, 2026Sep 2, 2026
Alembic Pharmaceuticals LimitedSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Dr. Reddy's Laboratories LimitedSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Dr. Reddys Laboratories Inc.,SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Proficient Rx LPSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Sportpharm LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.SUMATRIPTAN SUCCINATE 4 mg/.5mLJul 15, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.SUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026
Xellia Pharmaceuticals USA LLCSUMATRIPTAN SUCCINATE 6 mg/.5mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sumatriptan Succinate — NDC 62332-0656-01," retrieved September 3, 2026, https://drugdashboards.com/drug/62332065601.

Free to cite with attribution — see how the data is put together.